Full length article| Volume 228, P279-283, September 2018

Download started.


Comparison of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to decrease blood loss during laparoscopic myomectomy: Randomized clinical trial



      To compare the efficacy and safety of intramyometrial vasopressin plus rectal misoprostol with intramyometrial vasopressin alone to reduce blood loss during laparoscopic myomectomy.

      Study design

      A randomized, single-blind, controlled trial was conducted at All India Institute of Medical Sciences, New Delhi, India. Sixty women with symptomatic leiomyoma scheduled for laparoscopic myomectomy were recruited for the study. Thirty women received intramyometrial vasopressin plus rectal misoprostol (30 min before procedure) (Group I) and 30 women received intramyometrial vasopressin alone (Group II) during laparoscopic myomectomy. The primary outcome measure was intra-operative blood loss during surgery. Secondary outcome measures included decrease in postoperative haemoglobin, ease of enucleation of myomas, duration of surgery, need for additional haemostatic measures or blood transfusion, intra- and postoperative morbidity, and duration of hospital stay.


      The baseline demographic features and characteristics of leiomyomas were comparable in both groups. The mean (±standard deviation) blood loss in Group I was 139 ± 96.7 ml, which was significantly less than that for Group II (206 ± 101.2 ml) (p = 0.008). The mean postoperative haemoglobin was 11.6 ± 1.3 g/dl in Group I and 10.0 ± 1.2 g/dl in Group II (p = 0.001). Although blood loss was not clinically significant in either group, the decrease in haemoglobin was significantly higher in Group II. The mean score for ease of enucleation (surgeon-rated measure) was significantly lower in Group I (2.6 ± 1.1) compared with Group II (3.4 ± 1.1) (p = 0.029). Intra- and postoperative vital signs, duration of surgery, need for blood transfusion and postoperative morbidity were comparable in both groups.


      The addition of rectal misoprostol to intramyometrial vasopressin led to a significant reduction in blood loss and decreased the postoperative drop in haemoglobin. The combination also improved the ease of enucleation of myomas.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Day Baird D.
        • Dunson D.B.
        • Hill M.C.
        • Cousins D.
        • Schectman J.M.
        High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
        Am J Obstet Gynecol. 2003; 188: 100-107
        • Seracchioli R.
        • Rossi S.
        • Govoni F.
        • Rossi E.
        • Venturoli S.
        • Bulletti C.
        • et al.
        Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy.
        Hum Reprod. 2000; 15: 2663-2668
        • Bonney V.
        The techniques and results of myomectomy.
        Lancet. 1931; 220: 171-177
        • Koh M.B.C.
        • Hunt B.J.
        The management of perioperative bleeding.
        Blood Rev. 2003; 17: 179-185
        • Kongnyuy E.J.
        • Wiysonge C.S.
        Interventions to reduce haemorrhage during myomectomy for fibroids.
        Cochrane Database Syst Rev. 2014; 8: CD005355
        • Dillon T.F.
        • Marbury B.E.
        • Bonsnes R.W.
        • Douglas R.G.
        • DuVigneaud V.
        Vasopressin as a hemostatic ingynecologic surgery: a preliminary report.
        Obstet Gynecol. 1958; 11: 363
        • Fletcher H.
        • Frederick H.
        • Hardie M.
        • Simeon D.
        A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy.
        Obstet Gynecol. 1996; 87: 1014-1018
        • Ragab A.
        • Khaiary M.
        • Badawy A.
        The use of single versus double dose of intra-vaginal prostaglandin E2 "misoprostol" prior to abdominal myomectomy: a randomized controlled clinical trial.
        J Reprod Infertil. 2014; 15: 152-156
        • Zieman M.
        • Fong S.K.
        • Benowitz N.L.
        • Banskter D.
        • Darney P.D.
        Absorption kinetics of misoprostol with oral or vaginal administration.
        Obstet Gynecol. 1997; 90: 88-92
        • Kalogiannidis I.
        • Xiromeritis P.
        • Prapas N.
        • Prapas Y.
        Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial.
        Clin Exp Obstet Gynecol. 2011; 38: 46-49
        • Iavazzo C.
        • Mamais I.
        • Gkegkes I.D.
        Use of misoprostol in myomectomy: a systematic review and meta-analysis.
        Arch Gynecol Obstet. 2015; 292: 1185-1191
        • Hobo R.
        • Netsu S.
        • Koyasu Y.
        • Tsutsumi O.
        Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assistedmyomectomy.
        Obstet Gynecol. 2009; 113: 484-486
        • Frederick J.
        • Fletcher H.
        • Simeon D.
        • Mullings A.
        • Hardie M.
        Intramyometrial vasopressin as a hemostatic agent during myomectomy.
        BJOG. 1994; 101: 435-437
        • Celik H.
        • Sapmaz E.
        Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy.
        Fertil Steril. 2003; 79: 1207-1210
        • Baxter G.S.
        • Clayton J.K.
        • Coleman R.A.
        • Marshall K.
        • Sangha R.
        • Senior J.
        Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
        Br J Pharmacol. 1995; 116: 1692-1696
        • Frederick S.
        • Frederick J.
        • Fletcher H.
        • Reid M.
        • Hardie M.
        • Gardner W.
        A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy.
        Fertil Steril. 2013; 100: 1044-1049
        • Song T.
        • Kim M.K.
        • Kim M.L.
        • Jung Y.W.
        • Yun B.S.
        • Seong S.J.
        Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial.
        Eur J Obstet Gynecol Reprod Biol. 2015; 195: 177-181
        • Niroomand N.
        • Hajiha S.
        • Tabrizi N.M.
        • Ghajarzadeh M.
        A single dose of misoprostol for reducing hemorrhage during myomectomy: a randomized clinical trial.
        Arch Gynecol Obstet. 2015; 292: 155-158
        • Khan R.U.
        • El-Refaey H.
        • Sharma S.
        • Sooranna D.
        • Stafford M.
        Oral, rectal, and vaginal pharmacokinetics of misoprostol.
        Obstet Gynecol. 2004; 103: 866-870